The investigators will test the hypothesis that the adverse effects of second-generation
antipsychotics exposure and the beneficial effects of long-chain omega-3 (LCn-3) fatty acids
are mediated by opposing effects on the enzyme implicated in the metabolic syndrome and
obesity.
Phase:
Phase 3
Details
Lead Sponsor:
University of Cincinnati
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)